Ascent Pharmahealth


  • Jan
    24
    By Sameer Ranjan Bakshi

    Bangalore-based Strides Arcolab has sold 94 per cent shareholding in Ascent Pharmahealth, its subsidiary with operations in Australia and Southeast Asia, to NYSE-listed Watson Pharmaceuticals for AU$ 375 million (Rs

  • Mar
    16
    By PTI

    Drug maker Strides Arcolab today said it is in talks with Ascent Pharmahealth, listed on the Australian Stock Exchange, for acquiring a minority stake in the company.